Sumitomo Dainippon Pharma Co., Ltd.

Japan

  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Jun 27, 2017
Prev close: 1,549
Jun 27, 2017
Market cap:
Market cap(USD):
616,347.34M
5,516.64M
Shares: 397.90M

Currency in JPY

Company profile

Market(Ticker): TKS(4506)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Full time employees: 6,492

Business summary

Sumitomo Dainippon Pharma Co., Ltd. engages in the manufacture, sale, import, and export of pharmaceuticals products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment handles the creation of new pharmaceutical products. The Other Business segment division includes food ingredients and additives, chemical products materials, veterinary drugs, and diagnostics. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.

In the news

Financial highlights

Mar 2017

  • Local currency
  • US Dollar
Revenue 411,645M
Gross profit 305,913M
Operating income 52,759M
Income before tax 47,217M
Net income 28,991M
EBITDA 71,376M
Diluted EPS 72.97
Dividends per share 18
Total assets 793,950M
Total liabilities 333,292M
Total equity 460,656M
Operating cash flow 21,624M

Currency in JPY

Revenue 3,801.40M
Gross profit 2,825.00M
Operating income 487.21M
Income before tax 436.03M
Net income 267.72M
EBITDA 659.13M
Diluted EPS 0.67
Dividends per share 0.16
Total assets 7,125.10M
Total liabilities 2,991.04M
Total equity 4,134.03M
Operating cash flow 199.69M

Currency in USD

Valuation measures

Mar 2017

PER 25.18
ROA 3.86%
ROE 6.39%
Operating margin 12.81%
Profit margin 7.04%

Key executive

  • President, CEO & Representative Director: Masayo Tada
  • General Manager-Research Technology: Yoshiharu Ikeda
  • Director, Executive Officer & Head-Regenerative: Toru Kimura
  • Director & Executive Officer: Nobuyuki Hara
  • Executive Officer: Chiang J. Li

Share holders

  • Sumitomo Chemical Co., Ltd.(50.5%)
  • Inabata & Co., Ltd.(6.4%)
  • Nomura Asset Management Co., Ltd.(2.6%)
  • Nippon Life Insurance Co.(1.9%)
  • Sumitomo Mitsui Banking Pension Fund(1.7%)
  • Nikko Asset Management Co., Ltd.(1.4%)
  • Sumitomo Life Insurance Co.(1.4%)
  • MS&AD Insurance Group Holdings, Inc.(1.4%)
  • Daiwa Asset Management Co. Ltd.(1.3%)
  • The Vanguard Group, Inc.(0.9%)

Address

  • Website: http://www.ds-pharma.co.jp
  • Address: 2-6-8 Dosho-machi, Chuo-Ku, Osaka, 541-0045, Japan
  • Phone: +81.6.6203.5321

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.